ATE275414T1 - Verfahren zur behandlung endzünlicher darmerkrankungen durch verwendung von choleratoxin untereinheit b - Google Patents

Verfahren zur behandlung endzünlicher darmerkrankungen durch verwendung von choleratoxin untereinheit b

Info

Publication number
ATE275414T1
ATE275414T1 AT00978467T AT00978467T ATE275414T1 AT E275414 T1 ATE275414 T1 AT E275414T1 AT 00978467 T AT00978467 T AT 00978467T AT 00978467 T AT00978467 T AT 00978467T AT E275414 T1 ATE275414 T1 AT E275414T1
Authority
AT
Austria
Prior art keywords
subject
treating
administering
endangestital
diseases
Prior art date
Application number
AT00978467T
Other languages
English (en)
Inventor
Warren Strober
Ivan J Fuss
Brian L Kelsall
Monica Boirivant
Original Assignee
Us Gov Health & Human Serv
Ist Superiore Sanita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv, Ist Superiore Sanita filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE275414T1 publication Critical patent/ATE275414T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00978467T 1999-11-12 2000-11-09 Verfahren zur behandlung endzünlicher darmerkrankungen durch verwendung von choleratoxin untereinheit b ATE275414T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16511199P 1999-11-12 1999-11-12
PCT/US2000/030837 WO2001034175A2 (en) 1999-11-12 2000-11-09 Methods of treating inflammatory bowel disease using cholera toxin b subunit

Publications (1)

Publication Number Publication Date
ATE275414T1 true ATE275414T1 (de) 2004-09-15

Family

ID=22597468

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00978467T ATE275414T1 (de) 1999-11-12 2000-11-09 Verfahren zur behandlung endzünlicher darmerkrankungen durch verwendung von choleratoxin untereinheit b

Country Status (6)

Country Link
EP (1) EP1231931B1 (de)
AT (1) ATE275414T1 (de)
AU (1) AU1592801A (de)
CA (1) CA2391415C (de)
DE (1) DE60013636T2 (de)
WO (1) WO2001034175A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10752662B2 (en) 2014-05-16 2020-08-25 University Of Oregon Anti-inflammatory compounds and methods of use
US20170096457A1 (en) * 2014-05-16 2017-04-06 University Of Oregon Anti-inflammatory compounds and methods of use
WO2022117823A1 (en) * 2020-12-04 2022-06-09 Valneva Se Methods and compositions for preventing and/or treating autoimmune diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513733D0 (en) * 1995-07-05 1995-09-06 Univ Bristol Therapeutic agents
WO1998016248A1 (en) * 1996-10-11 1998-04-23 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods for enhancing oral tolerance and treating autoimmune disease using inhibitors of interleukin-12
WO1999054452A1 (en) * 1998-04-22 1999-10-28 Loma Linda University Methods and substances for preventing and treating autoimmune disease

Also Published As

Publication number Publication date
WO2001034175A3 (en) 2002-01-17
WO2001034175A2 (en) 2001-05-17
CA2391415A1 (en) 2001-05-17
EP1231931A2 (de) 2002-08-21
AU1592801A (en) 2001-06-06
CA2391415C (en) 2013-08-06
DE60013636D1 (de) 2004-10-14
EP1231931B1 (de) 2004-09-08
DE60013636T2 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE69631134D1 (de) Verfahren zur bekämpfung infektiöser krankheiten unter verwendung dikationischer bis-benzimidazole
DE1043995T1 (de) INHIBIERUNG DER p38 KINASE-AKTIVITÄT DURCH DIE VERWENDUNG VON ARYL- UND HETEROARYLSUBSTITUIERTEN HARNSTOFFEN
DE69616376D1 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
ES2154253T1 (es) Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas.
DE69815090D1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69835823D1 (de) Verfahren zur behandlung von patienten die unter multipler sklerose leiden mit konsensus-interferon
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
DE69329779D1 (de) Verfahren zur behandlung geschädigter und verminderter zellen
DE69719539D1 (de) Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer-lymphozyten
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE69633393D1 (de) Mitteln zur behandlung von auto-immun krankheiten
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE275414T1 (de) Verfahren zur behandlung endzünlicher darmerkrankungen durch verwendung von choleratoxin untereinheit b
DE69221725D1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
ATE100331T1 (de) Verfahren zur behandlung von septischem schock.
DE69623316D1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
DE69924385D1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
UA23919A (uk) Спосіб в.і. миркіна лікування ожиріння
DE69433851D1 (de) Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv
DE60002172T2 (de) Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopenten-1-methanol in hbv
UA30956A (uk) Спосіб лікування алергічного риніту
DE69432517T2 (de) Verfahren zur vorhersage der effektivität der behandlung von tumoren durch in-vitro bestimmung der überlebens- und vermehrungsfähigkeit
UA36485A (uk) Спосіб лікування генералізованого пародонтиту

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1231931

Country of ref document: EP